Publications by authors named "Aaron Moss"

Claim this Profile
T
The Bots Ruining Social Science Are Not Bots at All.
Shalom N Jaffe, Aaron J Moss, Rachel Hartman, Cheskie Rosenzweig, Richa Gautam

Perspect Psychol Sci· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating CloudResearch's Approved Group as a solution for problematic data quality on MTurk.
David J Hauser, Aaron J Moss, Cheskie Rosenzweig, Shalom N Jaffe, Jonathan Robinson

Behav Res Methods· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it ethical to use Mechanical Turk for behavioral research? Relevant data from a representative survey of MTurk participants and wages.
Aaron J Moss, Cheskie Rosenzweig, Jonathan Robinson, Shalom N Jaffe, Leib Litman

Behav Res Methods· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do you know the Wooly Bully? Testing era-based knowledge to verify participant age online.
Rachel Hartman, Aaron J Moss, Israel Rabinowitz, Nathaniel Bahn, Cheskie Rosenzweig

Behav Res Methods· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Did people really drink bleach to prevent COVID-19? A guide for protecting survey data against problematic respondents.
Leib Litman, Zohn Rosen, Rachel Hartman, Cheskie Rosenzweig, Sarah L Weinberger-Litman, Aaron J Moss

PLoS One· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C.
Richard Kim, Alexis D Leal, Aparna Parikh, David P Ryan, Shining Wang, Aaron Moss

Cancer Chemother Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C.
Richard Kim, Alexis D Leal, Aparna Parikh, David P Ryan, Shining Wang, Aaron Moss

Cancer Chemother Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paranoia and belief updating during the COVID-19 crisis.
Praveen Suthaharan, Erin J Reed, Pantelis Leptourgos, Joshua G Kenney, Stefan Uddenberg, Aaron J Moss

Nat Hum Behav· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paranoia and belief updating during a crisis.
Praveen Suthaharan, Erin J Reed, Pantelis Leptourgos, Joshua Kenney, Stefan Uddenberg, Aaron J Moss

Res Sq· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic Stability on Mechanical Turk Despite COVID-19.
Aaron J Moss, Cheskie Rosenzweig, Jonathan Robinson, Leib Litman

Trends Cogn Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapped out or barely tapped? Recommendations for how to harness the vast and largely unused potential of the Mechanical Turk participant pool.
Jonathan Robinson, Cheskie Rosenzweig, Aaron J Moss, Leib Litman

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model-Informed Dose Selection for the First-in-Human Study of AVB-S6-500.
Laura Bonifacio, Michael Dodds, David Prohaska, Aaron Moss, Amato Giaccia

Clin Transl Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online panels in social science research: Expanding sampling methods beyond Mechanical Turk.
Jesse Chandler, Cheskie Rosenzweig, Aaron J Moss, Jonathan Robinson, Leib Litman

Behav Res Methods· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse.
Christopher J Endres, Aaron M Moss, Kazuya Ishida, Rajgopal Govindarajan, Jashvant D Unadkat

Biopharm Drug Dispos· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.
Aaron M Moss, Christopher J Endres, Ana Ruiz-Garcia, Doo-Sup Choi, Jashvant D Unadkat

Mol Pharm· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of nucleoside transporters in the erythrocyte disposition and oral absorption of ribavirin in the wild-type and equilibrative nucleoside transporter 1-/- mice.
Christopher J Endres, Aaron M Moss, Rajgopal Govindarajan, Doo-Sup Choi, Jashvant D Unadkat

J Pharmacol Exp Ther· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes.
Christopher J Endres, Aaron M Moss, Ban Ke, Rajgopal Govindarajan, Doo-Sup Choi

J Pharmacol Exp Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics in drug discovery.
Ana Ruiz-Garcia, Marival Bermejo, Aaron Moss, Vicente G Casabo

J Pharm Sci· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis